...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: REPROGRAM - trial with RVX208.

I came across a reference to an EU funded study, where a clinical trial with RVX208 is mentioned. However, I have not been able to find any data from the trial. 

If you click on the link below and search for RVX208, you'll find the following:

"In parallel, we initiated a clinical study to investigate the impact of the bromodomain inhibitor (RVX-208) on the inflammatory state in patients."

https://cordis.europa.eu/project/id/667837/reporting

 

Does anyone know what came out of this study?

 

Thanks,

BKC

Share
New Message
Please login to post a reply